Literature DB >> 3058088

Methylphenidate and growth in hyperactive children. A controlled withdrawal study.

R G Klein1, B Landa, J A Mattes, D F Klein.   

Abstract

The effect of stimulants on growth has been controversial. Among hyperactive children receiving long-term methylphenidate hydrochloride treatment, we examined the effects of methylphenidate withdrawal on the growth of hyperactive children randomly assigned to be taken off, or remain on, the medication regimen over two consecutive summers. After one summer, no group difference in height was found, but weight was higher in the group that had been taken off methylphenidate therapy. In contrast, two summers of being off methylphenidate treatment had a significant positive effect on height but not on weight. The results document a linkage between exposure to methylphenidate and reduction in growth velocity. However, they do not address whether the medication has long-term effects on height.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058088     DOI: 10.1001/archpsyc.1988.01800360075011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  26 in total

1.  Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.

Authors:  Elena A P Germinario; Romano Arcieri; Maurizio Bonati; Alessandro Zuddas; Gabriele Masi; Stefano Vella; Flavia Chiarotti; Pietro Panei
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

Review 2.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

3.  Stimulants Use in Attention Deficit Hyperactivity Disorder (ADHD) Kids - Triumph or Tribulation?

Authors:  Ahmed Naguy
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2016-11-01

Review 4.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

Review 5.  Growth on stimulant medication; clarifying the confusion: a review.

Authors:  A Poulton
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

6.  A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.

Authors:  James G Waxmonsky; William E Pelham; Adriana Campa; Daniel A Waschbusch; Tan Li; Rebecca Marshall; Lysett Babocsai; Hugh Humphery; Elizabeth Gnagy; James Swanson; Tomasz Hanć; Negar Fallahazad; William E Pelham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-29       Impact factor: 8.829

7.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

8.  The role of pharmacotherapy in the management of self-regulation difficulties in young children.

Authors:  Pratibha N Reebye; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05

Review 9.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.